phytohaemagglutinin reduces fatty tumours

From: Doug Skrecky (oberon@vcn.bc.ca)
Date: Mon Jun 01 1998 - 09:28:37 MDT


Authors
  Pryme IF. Pusztai AJ. Grant G. Bardocz S.
Institution
  Department of Biochemistry and Molecular Biology, University of Bergen,
  Norway.
Title
  The effect of switching between a phytohemagglutinin-containing and a control
  diet on the growth and lipid content of a Krebs II lymphosarcoma tumor.
Source
  J Exp Ther Oncol. 1(5):273-7, 1996 Sep.
Abstract
  The present study concerns the importance of the timing of feeding mice a
  PHA-containing diet (7 mg g-1 diet) on tumor formation. The major decrease in
  tumor weight occurred in mice fed on the PHA diet for 11 days. A marked
  reduction was also observed in animals pre-fed for 3 days with PHA before
  tumor cells were injected and the diet then changed to lactalbumin, La. A
  large decrease in tumor weight was also evident when a change of diet from La
  to PHA was made on the day of tumor cell inoculation. Despite the presence of
  the developing tumor PHA was able to induce hyperplasia of the small
  intestine in all groups of animals fed PHA during a part or the whole of the
  experiment. The dry weights of tumors attained in each of the experimental
  groups plotted as a function of duration of PHA feeding, and the percentage
  lipid content of the tumors, mirrored almost exactly one another, suggesting
  that the availability of essential lipid material is severely reduced by the
  lectin. This would appear to have a major effect on the observed reduction in
  tumor growth.

Authors
  Pryme IF. Pusztai AJ. Grant G. Bardocz S.
Institution
  Department of Biochemistry and Molecular Biology, University of Bergen,
  Norway.
Title
  Phytohemagglutinin-induced gut hyperplasia and the growth of a mouse
  lymphosarcoma tumor.
Source
  J Exp Ther Oncol. 1(3):171-6, 1996 May.
Abstract
  NMRI mice injected subcutaneously with Krebs II lymphosarcoma cells and fed
  on a diet containing the kidney bean lectin phytohemagglutinin (PHA) within
  the range 0.45-7.0 mg/g diet, developed tumors during a 10 day period which
  on average were only 35% of the dry weight of tumors in lactalbumin (La) fed
  mice (control). The reduction in growth occurred in a dose-dependent manner
  in the range 0.45-3.5 mg/g diet. The degree of hyperplasia of the small
  intestine in response to feeding the PHA diets was higher in non-injected
  compared to injected mice. A lipolytic effect of PHA was observed above 1.75
  mg/g diet in control mice and the highest concentration had a major effect on
  body weight. Since the index of hyperplasia at the lowest PHA concentration
  tested did not correlate with the reduction in tumor size, it is suggested
  that other factors in addition to the initial lectin-induced gut hyperplasia
  are involved in slowing down the progression of tumor growth.



This archive was generated by hypermail 2.1.5 : Fri Nov 01 2002 - 14:49:09 MST